Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.

Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored.

You can separately subscribe to the Pharma & Biotech edition of the Global week in Review by subscribing by email, or selecting ‘all posts’ or Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: http://thinkipstrategy.com/subscribe/

Canada/Africa: Apotex ships patented AIDS drugs to Rwanda under Canada’s Access to Medicines Regime (CAMR) (Managing Intellectual Property) (GenericsWeb)

Consolidation in the generic drug industry to continue, according to experts (GenericsWeb)

BioScience Forum SPC powerpoint slides (The SPC blog)

Consolidation in the generic drug industry to continue, according to experts (GenericsWeb)

WHO asserts Global IP Health Strategy progressing but offers few details (Intellectual Property Watch)

Canada/Africa: Apotex ships patented AIDS drugs to Rwanda under Canada’s Access to Medicines Regime (CAMR) (Managing Intellectual Property) (GenericsWeb)

Europe: Pharmaceutical industry celebrates European Court of Justice decision that even dominant companies can take steps to protect against parallel trade: Sot Lelos Kai Sia EE & Ors v GlaxoSmithKline AEVE (Managing Intellectual Property)

Europe: Commercial and economic literature on patent term extension (The SPC blog)

India: Record number of pharmaceutical and chemical inventions patented in India in 2007-08 (RelatIP)

Japan: Teva to sell generic medicines in Japan in joint venture with Kowa Co (GenericsWeb)

South Africa: World Health Organisation warns against buying drugs from Sandoz South Africa plant (GenericsWeb)

Switzerland: Supplementary Protection Certificates in Switzerland (The SPC blog)

United States: In re Kubin: Update on the briefing in important Federal Circuit case relating to application of the nonobviousness and written description (Holman’s Biotech IP Blog)

United States: Boston University Professor releases report on the impact of marketing exclusivity on biologics innovation (Patent Docs)

United States: Consumer Watchdog and Public Patent Foundation argue human embryonic stem cell patent invalid in reexamination proceeding (Law360)

United States: Follow-on biologics in the news: Presidential candidates support follow-on biologics regulatory pathway (Patent Docs)

United States: Generic Pharmaceutical Association presses Hill on bioequivalence study registration under FDA Amendments Act (FDA Law Blog)

United States: Red or Blue – we’ll likely see biosimilars either way (Patent Baristas)

United States: When will the US develop concise generic biologic rules? (Biotech Blog)

United States: Patent for generating oxygen in a process that mimics photosynthesis (Competitive info)

Adderall (Dextroamphetamine/Racemic DL-ampthetamine) – US: Judge denies Sandoz’ bid for summary judgment of non infringement in patent dispute with Shir eover Adderall (Law360)

Carbatrol (Carbamazepine) – US: Judge refuses to grant summary judgment to Corepharma in patent dispute with Shire Laboratories over generic Carbatrol (Law360)

Clarinex (Desloratadine) – US: Sepracor, University of Massachusetts sue Pharmaceutical Associates over liquid Clarinex ANDA (Law360)

Enbrel (Etanercept) – US: Amgen secures favourable summary judgment ruling in ARIAD case (Patent Docs) (Law360)

Human granulocyte colony stimulating factor (G-CSF) product – EU: Teva receives EU authorisation for G-CSF biosimilar (Patent Docs)

Pulmicort (Budesonide) – US: Court denies Teva’s motion for summary judgment of no infringement in Pulmicort patent litigation brought by AstraZeneca (Law360) (SmartBrief)

Restoril (Temazepam) – US: Judge chides defendants, Mutual Pharmaceuticals, in Restoril patent suit (Law360)

Valcyte (Valganciclovir) – India: Cipla launches generic version of Roches patented Valganciclovir (PatentCircle) (SPICY IP)

Yaz (Drospirenone) – US: Bayer sues Sandoz, Watson over another Yaz patent (Law360)